"Synthetic biology tools like optogenetics allow us to precisely tune complex cellular processes, something traditional drug screening cannot do," said Maxwell Wilson, Ph.D., Co-Founder and Chief ...

A novel optogenetic screening platform enables a high-throughput screen and identified several integrated stress response-potentiating compounds.

A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

A landmark study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by ...

AssayQuant's KinSightTM Kinome profiling will be integrated into AsedaSciences' 3RnD® platform, enhancing data visualization to ac ...

GlaxoSmithKline is investing in artificial intelligence (AI) with the hope of radically cutting the time and money needed to develop a drug.

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

On this episode of Fortune’s Leadership Next podcast, cohosts Diane Brady, executive editorial director of the Fortune CEO ...

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are ...